The New England Journal Of Medicine 2026 PMID: 42253238, DOI: 10.1056/nejmoa2600751.Peer-Reviewed Original ResearchAltmetricConceptsGlucagon-like peptide-1Dose escalation periodPlacebo groupEarly discontinuationBody weightTreatment of adultsDouble-blind trialPhase 2 trialBaseline to weekObesity-related complicationsManagement of obesityObesity medicationsBody-mass indexMean BMIPlaceboEfficacy analysisNo deathsAdverse eventsCardiometabolic benefitsMean body weightGastrointestinal symptomsLifestyle modificationParticipantsEnd pointsAdults Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial Rosenstock J, Lingvay I, Ryan D, Jastreboff A , Kushner R, Acosta A, Blevins T, Choi M, Holmes F, Smith T, Connery L, Li Y, Liu M, Barth A, Butcher J, Civitarese A, Yue H, Coll B
Instead, she said my legitimate medical conditions were my "degenerative issues" and potentially, insomnia
Metodologa
Program Details General Category System requirements Download information Pricing Version History version 3.3.7 posted on 2026-07-23 Version History Changes in this update: * Fix stone weight values rounding incorrectly near the next stone * Improve maintenance settings so dates, labels, and color options are easier to read * Improve chart stability and prevent dosage and weight labels from overlapping * Improve onboarding stability when selecting height, weight, or measurement units * Fix removed schedule or water entries returning after relaunch and improve iCloud sync reliability 3.3.7 5d ago Changes in this update: * Fix dosage statistics showing incorrect sorting and weight changes * Add a before-first-dose section for a clearer view of weight history * Improve dosage and injection-site charts so smaller segments are easier to read * Fix maintenance weight charts in dark mode * Improve startup reliability, including issues that could prevent the app from opening * Improve data recovery with clear guidance and iCloud or local backup restore options * Add missing translations across several screens 3.3.6 Jul 13 Changes in this update: * Improve the new-user onboarding experience * Fix weight chart occasionally showing incorrect data * Fix long medication names getting cut off * Fix estimated medication level charts for edge cases 3.3.5 Jun 30 Changes in this update: * Fixes several small bugs and rare crashes * Updates to new-user experience 3.3.3 Jun 22 Changes in this update: * Fixes bug with new user experience * Fixes a crash related to your next scheduled shot * Fixes maintenance duration not matching between your Journey and Results * Improves reliability when deleting shots and medications * Adds request for feedback on Community Insights * Fixes the app icon styling 3.3.2 Jun 10 Changes in this update: * Fixes a crash related to your next scheduled shot * Fixes maintenance duration not matching between your Journey and Results * Improves reliability when deleting shots and medications * Adds request for feedback on Community Insights * Fixes the app icon styling 3.3.1 Jun 9 Changes in this update: * New sections on the Results screen: Dosage Stats and Injection Site Stats
Helps in the treatment of Alzheimers disease and Parkinsons disease: Its mechanism of promoting synaptic connectivity and neuronal survival makes it a candidate for neurodegenerative disease applications
6.3.1 Insulin sensitization IR is both a driver and a consequence of OS and HA in PCOS (135)
